Anupam Rasayan Shareholders Approve Milind Talathi as Independent Director

Anupam Rasayan India Limited , a leading specialty chemicals company, has successfully secured shareholder approval for the appointment of Mr. Milind Madan Talathi as an Additional Director, categorized as Non-Executive Independent Director, for a three-year term. The appointment, which was initially approved by the company's Board of Directors, received overwhelming support from shareholders through a postal ballot process.

Postal Ballot Results

The postal ballot conducted through remote e-voting concluded on December 22, 2025, with shareholders demonstrating strong confidence in the appointment. The voting results were disclosed on December 24, 2025, pursuant to Regulation 44 of SEBI Listing Regulations.

Voting Category:	Details
Total Votes Cast:	83,648,134
Votes in Favor:	83,557,964 (99.89%)
Votes Against:	90,170 (0.11%)
Voter Turnout:	73.47% of outstanding shares

The postal ballot notice was dispatched to shareholders on November 22, 2025, with the cut-off date set as November 20, 2025. The e-voting process commenced on November 23, 2025, and concluded on December 22, 2025.

Detailed Voting Breakdown by Category

The company has now released comprehensive voting statistics across different shareholder categories, showing broad-based support for the appointment.

Category:	Total Shares	Votes Polled	Turnout (%)	Votes in Favor	Votes Against
Promoter Group:	67,253,016	67,253,016	100.00%	67,253,016	0
Public Institutions:	9,220,959	720,776	7.82%	630,933	89,843
Public Non-Institutions:	37,374,335	15,674,342	41.94%	15,674,015	327

Appointment Details

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved Talathi's appointment for a term spanning from September 25, 2025, to September 24, 2028. With shareholder approval now secured, the appointment is formally effective.

Expertise and Background

Mr. Talathi brings a wealth of experience to Anupam Rasayan, with a career spanning around four decades in the chemical manufacturing sector. His expertise covers operations management, Environmental Health and Safety (EHS), Human Resources and Industrial Relations, Innovation and Supply Chain Management, and regulatory liaison.

Talathi's educational background includes a degree in Chemical Engineering from UDCT Mumbai, a Management degree from Pune University, and additional courses from prestigious institutions like IIM-A and TMTC.

Professional Journey

Throughout his illustrious career, Mr. Talathi has held several leadership positions in renowned companies. He started his career with Tata Group's Rallis India Ltd. in Chandigarh, served as President (Operations) at Century Enka Ltd. for their Pune & Mahad sites, held the position of COO at Gujarat Fluorochemicals in Dahej, and was appointed as Whole Time Director at ELANTAS Beck India Ltd., part of the ALTANA GmbH Group.

Additional Responsibilities and Industry Involvement

In addition to his role as an Independent Director, Talathi will also join Anupam Rasayan's Risk Management Committee, effective from his appointment date. He is actively involved in various industry roles, including Chairman of the Chemical Sector Vertical at MCCIA, Member of the Start-up Advisory Council at MIT-TBI, and mentor to several entrepreneurs.

Compliance and Formal Documentation

The company has confirmed that Mr. Talathi meets the independence criteria as prescribed under the Companies Act, 2013 and SEBI Listing Regulations. The formal minutes of the postal ballot resolution were entered into the company's records on January 7, 2026, with proper intimation sent to BSE Limited and National Stock Exchange of India Limited.

This appointment, now formally approved by shareholders, underscores Anupam Rasayan's commitment to strengthening its board with experienced professionals, potentially enhancing its strategic decision-making capabilities in the competitive specialty chemicals market.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.77%	-1.27%	+5.51%	+14.82%	+86.55%	+148.61%

Anupam Rasayan India Limited , a leading custom synthesis and specialty chemical player, has announced significant expansions in its long-term contracts and reported robust financial results for the first quarter of fiscal year 2026.

Contract Expansions and Sustainable Growth

The company has successfully expanded its long-term contracts with global leaders in the agrochemical and specialty chemical sectors. This strategic move aligns with Anupam Rasayan's commitment to sustainable growth and strengthening its position in the global market.

As part of its growth strategy, the company is incorporating value-added molecules into its operations. This initiative is expected to enhance its product portfolio and cater to the evolving needs of its global clientele.

Anupam Rasayan is also making substantial investments in eco-friendly processes, underscoring its dedication to sustainable practices in the chemical industry. These investments are likely to improve the company's environmental footprint while meeting the increasing demand for environmentally responsible chemical solutions.

Strong Financial Performance in Q1 FY26

The company's financial results for the quarter ended June 30, 2025, reflect significant growth:

Consolidated total revenue stood at ₹4,907.00 million, marking an impressive year-on-year growth of 89%.
EBITDA (including other income) reached ₹1,292.00 million, up by 118% compared to the same quarter last year.
Profit After Tax (PAT) surged to ₹485.00 million, representing a substantial increase of 297% year-on-year.

Key Financial Highlights

Particulars (₹ in million)	Q1 FY26	Q1 FY25	YoY Growth
Total Revenue	4,907.00	2,603.00	89%
EBITDA	1,292.00	592.00	118%
Profit After Tax	485.00	122.00	297%

The EBITDA margin for Q1 FY26 stood at an impressive 26%, indicating strong operational efficiency.

Management Commentary

Mr. Anand Desai, Managing Director of Anupam Rasayan, commented on the performance: "We strongly believe that the sectoral trends are in our favor, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan."

He further added, "During Q1 FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at ₹14,646.00 crore, reflecting the strong growth momentum in our business."

Business Expansion and Future Outlook

Anupam Rasayan has added one new product in Q1 FY26, taking its total product count to 80. The company's diverse product portfolio caters to various sectors, including agrochemicals, personal care, and pharmaceuticals.

The company's order book of ₹14,646.00 crore demonstrates strong future growth potential and reflects the confidence of global clients in Anupam Rasayan's capabilities.

As Anupam Rasayan continues to expand its long-term contracts, invest in eco-friendly processes, and deliver strong financial results, it is well-positioned to capitalize on the growing demand for specialty chemicals in both domestic and international markets.